Related Experiment Video
Updated: Sep 18, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
Published on: October 29, 2014
Abstract:
Pseudomonas aeruginosa seldom invades the body except in persons or in organs lacking natural defenses, and usually the infection is chronic rather than acute, evoking little systemic response. When introduced into the cornea, however, as in penetration by a foreign body or in contaminated medicines, it acts with extreme virulence, in many cases causing blindness and even necessitating enucleation. Although many attempts at control of Ps. aeruginosa, even with powerful antibiotics, have been unsuccessful, polymyxin B appeared to have good effect and was tested in experimental infection of the cornea in rabbits. It was demonstrated by preliminary studies in vitro that polymyxin B was effective against nine strains of Ps. aeruginosa which on inoculation caused rapidly progressive ulcers in the corneas of rabbits.A strain of proved virulence was introduced into both eyes of each of 18 rabbits. The left eyes only were treated with subconjunctival injections at 48-hour intervals of a solution of polymyxin B, to which epinephrine was added as a vasoconstrictor to prevent rapid dispersion. The right eyes remained untreated as controls. In five of the six rabbits treated immediately after inoculation, the treated eyes remained clear, while moderate infiltration developed in the sixth. In the six rabbits not treated for 24 hours after inoculation, ulcers developed but remained localized during therapy. In those not treated for 48 hours after inoculation, ulcers developed before treatment began but did not spread as rapidly as in the controls. Hyaluronidase was added to the preparation for half the rabbits in each group but had no perceptible beneficial effect.
Insights
Polymyxin B effectively treated Pseudomonas aeruginosa eye infections in rabbits, preventing or localizing corneal ulcers. Early treatment showed the best results, with hyaluronidase having no added benefit.
Area of Science:
- Ophthalmology
- Microbiology
- Infectious Diseases
Background:
- Pseudomonas aeruginosa typically causes chronic infections with minimal systemic response.
- Ocular P. aeruginosa infections, often from trauma or contaminated substances, exhibit extreme virulence, leading to blindness.
- Previous antibiotic treatments for P. aeruginosa have shown limited success.
Purpose of the Study:
- To evaluate the efficacy of polymyxin B in treating experimental Pseudomonas aeruginosa keratitis in rabbits.
- To determine the impact of treatment timing on the effectiveness of polymyxin B.
Main Methods:
- Experimental Pseudomonas aeruginosa keratitis was induced in 18 rabbits.
- Treated eyes received subconjunctival polymyxin B injections with epinephrine every 48 hours; control eyes were untreated.
- Treatment was initiated immediately, 24 hours, or 48 hours post-inoculation.
Main Results:
- Immediate polymyxin B treatment prevented corneal ulcers in 5 out of 6 rabbits.
- Delayed treatment (24 or 48 hours) localized ulcer progression compared to controls.
- Addition of hyaluronidase to polymyxin B showed no discernible benefit.
Conclusions:
- Polymyxin B demonstrates significant efficacy in managing Pseudomonas aeruginosa keratitis in rabbits.
- Timely administration of polymyxin B is crucial for optimal outcomes in P. aeruginosa ocular infections.
- Further research may explore optimized polymyxin B formulations for ocular infections.
Related Concept Videos
Microbiome of the Eye
Glaucoma: Overview
Pneumonia I: Introduction
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

